PANCURONIUM Side Effects

5362646-6 | Deafness Neurosensory
on Jun 01, 2007 Female patient from JAPAN , child 5 years of age, was diagnosed with mechanical ventilation and was treated with Pancuronium (View Usage). Patient experienced the following unwanted or unexpected effects: deafness neurosensory. Pancuronium dosage: Intravenous Drip. During the same period patient was treated with DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), DOBUTAMINE HYDROCHLORIDE (View Dobutamine Hydrochloride Review and Dobutamine Hydrochloride Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), ALPROSTADIL (View Alprostadil Review and Alprostadil Label ), CEFMETAZOLE SODIUM (View Cefmetazole Sodium Review and Cefmetazole Sodium Label ), CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ).

5022090-8 | Anaphylactic Shock
Patient was taking Pancuronium (View Usage). Patient had the following side effects: anaphylactic shock on May 29, 2006 from FRANCE Additional patient health information: Female patient , 42 years of age, was diagnosed with anaesthesia and. Pancuronium dosage: Intraveous (nos). During the same period patient was treated with THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ). Patient was hospitalized.

5006708-1 | Allergy Test Positive, Anaphylactic Shock
Adverse event was reported on May 04, 2006 by a Female patient taking Pancuronium (View Usage) (Dosage: Intravenous (nos)) was diagnosed with anaesthesia and. Location: FRANCE , 42 years of age, After Pancuronium was administered, patient had the following side effects: allergy test positive, anaphylactic shock. During the same period patient was treated with THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ). Patient was hospitalized.

4847479-9 | Deafness Neurosensory, Hypoxia
on Nov 21, 2005 Female patient from JAPAN , child 5 years of age, was diagnosed with life support and was treated with Pancuronium (View Usage). Patient experienced the following unwanted or unexpected effects: deafness neurosensory, hypoxia. Pancuronium dosage: . During the same period patient was treated with DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), ALPROSTADIL (View Alprostadil Review and Alprostadil Label ), CEFMETAZOLE SODIUM (View Cefmetazole Sodium Review and Cefmetazole Sodium Label ), CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ).


4726260-5 | Deafness Neurosensory, Renal Failure Acute, Speech Disorder Developmental
on Jul 14, 2005 Male patient from JAPAN , child 3 years of age, was diagnosed with life support and was treated with Pancuronium (View Usage). Patient had the following side effects: deafness neurosensory, renal failure acute, speech disorder developmental. Pancuronium dosage: . During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), LOOP DIURETIC (View Loop Diuretic Review and Loop Diuretic Label ).

4726259-9 | Deafness Neurosensory
Patient was taking Pancuronium (View Usage). After Pancuronium was administered, patient had the following side effects: deafness neurosensory on Jul 14, 2005 from JAPAN Additional patient health information: Female patient , child 5 years of age, was diagnosed with life support and. Pancuronium dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), AMINOGLYCOSIDE (View Aminoglycoside Review and Aminoglycoside Label ), LOOP DIURETIC (View Loop Diuretic Review and Loop Diuretic Label ).

4620886-5 | Anaesthetic Complication Neurological, Areflexia, Coma, Haemorrhage, Muscle Twitching
Adverse event was reported on Mar 17, 2005 by a Female patient taking Pancuronium (View Usage) (Dosage: 10 Mg Once, Intravenous Bolus) was diagnosed with induction and maintenance of anaesthesia and. Location: , 67 years of age, Patient experienced the following unwanted or unexpected effects: anaesthetic complication neurological, areflexia, coma, haemorrhage, muscle twitching. During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), SUFFENTANIL (View Suffentanil Review and Suffentanil Label ), CRYSTALLOID SOLUTION (View Crystalloid Solution Review and Crystalloid Solution Label ), PENTASTARCH (View Pentastarch Review and Pentastarch Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), NOREPINEPHRINEQ (View Norepinephrineq Review and Norepinephrineq Label ), MILRINONE (View Milrinone Review and Milrinone Label ), HEPARIN (View Heparin Review and Heparin Label ).